Quanex Building Products Corporation (NYSE:NX)
(“Quanex” or the “Company”) today announced its results for the
three months ended April 30, 2019.
Bill Griffiths, Chairman, President and Chief
Executive Officer, stated, “We performed well during the second
quarter from an operational standpoint and realized margin
expansion in all segments, including an almost 400 basis point
increase in our European Fenestration segment. On a
consolidated basis, we realized margin expansion of approximately
70 basis points. On the revenue side, solid growth of more
than 15%, excluding foreign exchange impact, in our European
Fenestration segment was somewhat offset by softer sales in the
U.S., mainly due to inclement weather and customer inventory
destocking. Despite this softness in the U.S., sales in our
North American Fenestration segment grew at 1.0% during the
quarter, which compares favorably to Ducker’s latest window
shipment estimate of negative 4.0% growth for the three months
ended March 31, 2019. We also more than doubled the amount of
free cash flow generated during the quarter, which allowed us to
pay down $5 million in bank debt and buyback approximately $2.7
million in stock.
“We continue to expect margin expansion on a
consolidated basis for the full year as operational efficiency
gains continue, volume ramps into the selling season and we benefit
from pricing actions that were implemented early this year.
Going forward, our intention is to continue deleveraging the
balance sheet while opportunistically repurchasing stock. Our
growth expectations for the full year haven’t materially changed
with respect to our North American and European Fenestration
segments; however, top line results in our North American Cabinet
Components segment have been weaker than expected, but consistent
with the latest industry data. As such, we now expect full
year 2019 consolidated revenue growth of 2% to 3%, but we are
converting well and are maintaining our Adjusted EBITDA guidance of
$97 million to $107 million.” (See Forward Looking Statements
and Non-GAAP Terminology Definitions and Disclaimers sections for
additional information)
Second Quarter 2019 Results
Summary
The Company reported the following selected
financial results:
|
|
Three Months Ended April 30, |
|
|
2019 |
|
2018 |
Net Sales |
|
$218.2 |
|
$214.2 |
Net (Loss) Income |
|
($24.0) |
|
$4.1 |
Diluted EPS |
|
($0.73) |
|
$0.12 |
|
|
|
|
|
Adjusted Net Income |
|
$6.3 |
|
$4.8 |
Adjusted Diluted EPS |
|
$0.19 |
|
$0.14 |
Adjusted EBITDA |
|
$23.4 |
|
$21.3 |
|
|
|
|
|
Cash provided by operating
activities |
|
$20.4 |
|
$13.4 |
Free Cash Flow |
|
$13.6 |
|
$6.0 |
(See Non-GAAP
Terminology Definitions and Disclaimers section, Non-GAAP Financial
Measure Disclosure table Selected Segment Data table and Free Cash
Flow Reconciliation table for additional information) |
The increase in net sales during the second quarter of 2019 was
largely due to above market growth in the European Fenestration
segment coupled with price increases related to raw material
inflation recovery. (See Sales Analysis table for additional
information)
The decrease in reported earnings was primarily
the result of a $30.0 million, or $0.91 per diluted share, non-cash
goodwill impairment in the North American Cabinet Components
segment, mostly due to softer than expected sales. The
increase in adjusted earnings was mainly attributable to
operational efficiency gains and the successful implementation of
pricing initiatives.
As of April 30, 2019, Quanex’s leverage ratio of
Net Debt to LTM Adjusted EBITDA decreased to 2.3x. Quanex
continues to expect to end fiscal 2019 with a leverage ratio
between 1.5x and 2.0x. (See Non-GAAP Terminology Definitions
and Disclaimers section for additional information)
Share Repurchases
The Company’s Board of Directors authorized a
$60 million share repurchase program in September of 2018.
Repurchases under this program will be made in open market
transactions or privately negotiated transactions, subject to
market conditions, applicable legal requirements and other relevant
factors. The program does not have an expiration date or a
limit on the number of shares that may be repurchased. During
the three months ended April 30, 2019, Quanex repurchased 171,016
shares of common stock for approximately $2.7 million at an average
price of $15.71 per share. As of April 30, 2019,
approximately $23.3 million remained under the existing share
repurchase authorization.
Recent Events
The Company’s Board of Directors declared a
quarterly cash dividend of $0.08 per share on Quanex’s common
stock, payable June 28, 2019, to shareholders of record on June 14,
2019.
Conference Call and Webcast
Information
The Company has scheduled a conference call for
Wednesday, June 5, 2019, at 11:00 a.m. ET (10:00 a.m. CT). To
participate in the conference call dial (877) 388-2139 for domestic
callers and (541) 797-2983 for international callers, in both cases
using the conference passcode 4390268, and ask for the Quanex call
a few minutes prior to the start time. A link to the live
audio webcast will also be available on the Company’s website at
http://www.quanex.com in the Investors section under Presentations
& Events. A telephonic replay of the call will be
available approximately two hours after the live broadcast ends and
will be accessible through June 12, 2019. To access the
replay dial (855) 859-2056 for domestic callers and (404) 537-3406
for international callers, in both cases referencing conference
passcode 4390268.
About Quanex
Quanex Building Products Corporation is an
industry-leading manufacturer of components sold to Original
Equipment Manufacturers (OEMs) in the building products
industry. Quanex designs and produces energy-efficient
fenestration products in addition to kitchen and bath cabinet
components. For more information contact Scott Zuehlke, Vice
President, Investor Relations & Treasurer, at 713-877-5327 or
scott.zuehlke@quanex.com.
Non-GAAP Terminology Definitions and
Disclaimers
Adjusted Net Income (Loss) (defined as net
income further adjusted to exclude purchase price accounting
inventory step-ups, transaction costs, gain/loss on the sale of
fixed assets, restructuring charges, other net adjustments related
to foreign currency transaction gain/loss and effective tax rates
reflecting impacts of adjustments on a with and without basis) and
Adjusted EPS are non-GAAP financial measures that Quanex believes
provide a consistent basis for comparison between periods and more
accurately reflects operational performance, as they are not
influenced by certain income or expense items not affecting ongoing
operations. EBITDA (defined as net income or loss before interest,
taxes, depreciation and amortization and other, net) and Adjusted
EBITDA (defined as EBITDA further adjusted to exclude purchase
price accounting inventory step-ups, transaction costs, gain/loss
on the sale of fixed assets, and restructuring charges) are
non-GAAP financial measures that the Company uses to measure
operational performance and assist with financial
decision-making. When Quanex provides expectations for
Adjusted EBITDA on a forward-looking basis, a reconciliation of the
differences between the non-GAAP expectations and corresponding
GAAP measures is generally not available without unreasonable
effort. The Company is not able to provide reconciliations of
Adjusted EBITDA to GAAP financial measures because certain items
required for such reconciliations are outside of Quanex’s control
and/or cannot be reasonably predicted, such as the provision for
income taxes. Net Debt is calculated using the sum of current
maturities of long-term debt and long-term debt, minus cash and
cash equivalents. The leverage ratio of Net Debt to LTM
Adjusted EBITDA is a financial measure that the Company believes is
useful to investors and financial analysts in evaluating Quanex’s
leverage. In addition, with certain limited adjustments, this
leverage ratio is the basis for a key covenant in the Company’s
credit agreement. Free Cash Flow is a non-GAAP measure
calculated using cash provided by operating activities less capital
expenditures. Free Cash Flow is measured before application
of certain contractual commitments (including capital lease
obligations), and accordingly is not a true measure of Quanex’s
residual cash flow available for discretionary expenditures.
The Company believes that the presented non-GAAP measures provide a
consistent basis for comparison between periods, and will assist
investors in understanding Quanex’s financial performance when
comparing results to other investment opportunities. The
presented non-GAAP measures may not be the same as those used by
other companies. The Company does not intend for this
information to be considered in isolation or as a substitute for
other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
Statements that use the words “estimated,”
“expect,” “could,” “should,” “believe,” “will,” “might,” or similar
words reflecting future expectations or beliefs are forward-looking
statements. The forward-looking statements include, but are not
limited to, the Company’s future operating results, future
financial condition, future uses of cash and other expenditures,
expenses and tax rates, expectations relating to Quanex’s industry,
and the Company’s future growth, including any guidance discussed
in this press release. The statements and guidance set forth
in this release are based on current expectations. Actual
results or events may differ materially from this release.
For a complete discussion of factors that may affect Quanex’s
future performance, please refer to the Company’s Annual Report on
Form 10-K for the fiscal year ended October 31, 2018, under the
sections entitled “Cautionary Note Regarding Forward-Looking
Statements” and “Risk Factors”. Any forward-looking
statements in this press release are made as of the date hereof,
and Quanex undertakes no obligation to update or revise any
forward-looking statements to reflect new information or
events.
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
CONDENSED CONSOLIDATED STATEMENTS OF NET (LOSS)
INCOME |
(In thousands, except per share data) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended April 30, |
|
Six Months Ended April 30, |
|
|
|
2019 |
|
|
2018 (1) |
|
|
2019 |
|
|
2018 (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
218,203 |
|
|
$ |
214,212 |
|
|
$ |
415,011 |
|
|
$ |
405,878 |
|
Cost of sales |
|
|
171,378 |
|
|
|
169,030 |
|
|
|
329,935 |
|
|
|
323,546 |
|
Selling, general and
administrative |
|
|
23,722 |
|
|
|
23,863 |
|
|
|
51,748 |
|
|
|
47,971 |
|
Restructuring charges |
|
|
84 |
|
|
|
242 |
|
|
|
187 |
|
|
|
608 |
|
Depreciation and
amortization |
|
|
12,404 |
|
|
|
13,310 |
|
|
|
24,976 |
|
|
|
26,583 |
|
Asset impairment charges |
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
Operating (loss) income |
|
|
(19,363 |
) |
|
|
7,767 |
|
|
|
(21,813 |
) |
|
|
7,170 |
|
Interest expense |
|
|
(2,602 |
) |
|
|
(2,502 |
) |
|
|
(5,044 |
) |
|
|
(4,943 |
) |
Other, net |
|
|
(54 |
) |
|
|
264 |
|
|
|
202 |
|
|
|
689 |
|
(Loss) income before income
taxes |
|
|
(22,019 |
) |
|
|
5,529 |
|
|
|
(26,655 |
) |
|
|
2,916 |
|
Income tax (expense)
benefit |
|
|
(1,955 |
) |
|
|
(1,393 |
) |
|
|
(968 |
) |
|
|
6,167 |
|
Net (loss) income |
|
$ |
(23,974 |
) |
|
$ |
4,136 |
|
|
$ |
(27,623 |
) |
|
$ |
9,083 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income per common
share, basic |
|
$ |
(0.73 |
) |
|
$ |
0.12 |
|
|
$ |
(0.84 |
) |
|
$ |
0.26 |
|
(Loss) income per common
share, diluted |
|
$ |
(0.73 |
) |
|
$ |
0.12 |
|
|
$ |
(0.84 |
) |
|
$ |
0.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares
outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
32,951 |
|
|
|
34,796 |
|
|
|
33,026 |
|
|
|
34,731 |
|
Diluted |
|
|
32,951 |
|
|
|
35,115 |
|
|
|
33,026 |
|
|
|
35,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends per share |
|
$ |
0.08 |
|
|
$ |
0.04 |
|
|
$ |
0.16 |
|
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Updated to reflect adoption of ASU 2017-07. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
CONDENSED CONSOLIDATED BALANCE SHEETS |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
April 30, 2019 |
|
|
October 31, 2018 (1) |
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
20,262 |
|
|
$ |
29,003 |
|
Accounts receivable, net |
|
|
80,646 |
|
|
|
84,014 |
|
Inventories, net |
|
|
86,581 |
|
|
|
70,730 |
|
Prepaid and other current assets |
|
|
8,458 |
|
|
|
7,296 |
|
Total current assets |
|
|
195,947 |
|
|
|
191,043 |
|
Property, plant and equipment,
net |
|
|
197,182 |
|
|
|
201,370 |
|
Goodwill |
|
|
190,638 |
|
|
|
219,627 |
|
Intangible assets, net |
|
|
114,921 |
|
|
|
121,919 |
|
Other assets |
|
|
8,354 |
|
|
|
9,255 |
|
Total assets |
|
$ |
707,042 |
|
|
$ |
743,214 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
48,743 |
|
|
$ |
52,389 |
|
Accrued liabilities |
|
|
31,554 |
|
|
|
45,968 |
|
Income taxes payable |
|
|
2,971 |
|
|
|
2,780 |
|
Current maturities of long-term debt |
|
|
1,082 |
|
|
|
1,224 |
|
Total current liabilities |
|
|
84,350 |
|
|
|
102,361 |
|
Long-term debt |
|
|
224,743 |
|
|
|
209,332 |
|
Deferred pension and
postretirement benefits |
|
|
5,797 |
|
|
|
4,218 |
|
Deferred income taxes |
|
|
16,417 |
|
|
|
17,510 |
|
Other liabilities |
|
|
14,847 |
|
|
|
14,571 |
|
Total liabilities |
|
|
346,154 |
|
|
|
347,992 |
|
Stockholders’ equity: |
|
|
|
|
|
|
|
|
Common stock |
|
|
374 |
|
|
|
374 |
|
Additional paid-in-capital |
|
|
253,679 |
|
|
|
254,678 |
|
Retained earnings |
|
|
210,406 |
|
|
|
243,904 |
|
Accumulated other comprehensive loss |
|
|
(28,127 |
) |
|
|
(30,705 |
) |
Treasury stock at cost |
|
|
(75,444 |
) |
|
|
(73,029 |
) |
Total stockholders’ equity |
|
|
360,888 |
|
|
|
395,222 |
|
Total liabilities and stockholders' equity |
|
$ |
707,042 |
|
|
$ |
743,214 |
|
|
|
|
|
|
|
|
|
|
(1) Updated to reflect accounting change to FIFO cost method. |
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOW |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended April 30, |
|
|
|
2019 |
|
|
|
2018 |
|
Operating activities: |
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(27,623 |
) |
|
$ |
9,083 |
|
Adjustments to reconcile net (loss) income to cash provided by
operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
24,976 |
|
|
|
26,583 |
|
Stock-based compensation |
|
|
1,043 |
|
|
|
211 |
|
Deferred income tax |
|
|
(1,256 |
) |
|
|
(8,087 |
) |
Asset impairment charges |
|
|
29,978 |
|
|
|
- |
|
Other, net |
|
|
1,078 |
|
|
|
(321 |
) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Decrease in accounts receivable |
|
|
3,479 |
|
|
|
3,357 |
|
Increase in inventory |
|
|
(15,522 |
) |
|
|
(4,623 |
) |
Decrease in other current assets |
|
|
(681 |
) |
|
|
(1,047 |
) |
(Decrease) increase in accounts payable |
|
|
(2,617 |
) |
|
|
378 |
|
Decrease in accrued liabilities |
|
|
(14,716 |
) |
|
|
(5,220 |
) |
Increase in income taxes payable |
|
|
183 |
|
|
|
25 |
|
Increase in deferred pension and postretirement benefits |
|
|
1,567 |
|
|
|
1,457 |
|
Decrease in other long-term liabilities |
|
|
(131 |
) |
|
|
(38 |
) |
Other, net |
|
|
385 |
|
|
|
(143 |
) |
Cash provided by operating
activities |
|
|
143 |
|
|
|
21,615 |
|
Investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(13,022 |
) |
|
|
(15,213 |
) |
Proceeds from disposition of capital assets |
|
|
298 |
|
|
|
180 |
|
Cash used for investing
activities |
|
|
(12,724 |
) |
|
|
(15,033 |
) |
Financing activities: |
|
|
|
|
|
|
|
|
Borrowings under credit facilities |
|
|
57,500 |
|
|
|
21,500 |
|
Repayments of credit facility borrowings |
|
|
(42,500 |
) |
|
|
(34,000 |
) |
Repayments of other long-term debt |
|
|
(784 |
) |
|
|
(442 |
) |
Common stock dividends paid |
|
|
(5,335 |
) |
|
|
(2,800 |
) |
Issuance of common stock |
|
|
27 |
|
|
|
2,564 |
|
Payroll tax paid to settle shares forfeited upon vesting of
stock |
|
|
(322 |
) |
|
|
(706 |
) |
Purchase of treasury stock |
|
|
(4,702 |
) |
|
|
- |
|
Cash provided by (used for)
financing activities |
|
|
3,884 |
|
|
|
(13,884 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(44 |
) |
|
|
(55 |
) |
Decrease in cash and cash
equivalents |
|
|
(8,741 |
) |
|
|
(7,357 |
) |
Cash and cash equivalents at
beginning of period |
|
|
29,003 |
|
|
|
17,455 |
|
Cash and cash equivalents at
end of period |
|
$ |
20,262 |
|
|
$ |
10,098 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
FREE CASH FLOW RECONCILIATION |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
The following table reconciles the Company's calculation of Free
Cash Flow, a non-GAAP measure, to its most directly comparable GAAP
measure. The Company defines Free Cash Flow as cash provided
by operating activities less capital expenditures. |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended April 30, |
|
Six Months Ended April 30, |
|
|
|
2019 |
|
|
|
2018 |
|
|
|
2019 |
|
|
|
2018 |
|
Cash provided by operating
activities |
|
$ |
20,386 |
|
|
$ |
13,423 |
|
|
$ |
143 |
|
|
$ |
21,615 |
|
Capital expenditures |
|
|
(6,751 |
) |
|
|
(7,402 |
) |
|
|
(13,022 |
) |
|
|
(15,213 |
) |
Free Cash Flow |
|
$ |
13,635 |
|
|
$ |
6,021 |
|
|
$ |
(12,879 |
) |
|
$ |
6,402 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
NON-GAAP FINANCIAL MEASURE DISCLOSURE |
(In thousands, except per share data) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
Six Months Ended |
|
Reconciliation of
Adjusted Net Income and Adjusted EPS |
|
April 30, 2019 |
|
|
April 30, 2018 |
|
|
April 30, 2019 |
|
|
April 30, 2018 |
|
|
|
Net Income |
|
Diluted EPS |
|
|
Net Income |
|
Diluted EPS |
|
|
Net Income |
|
Diluted EPS |
|
|
Net Income |
|
Diluted EPS |
|
Net (loss) income as reported |
|
$ |
(23,974 |
) |
|
$ |
(0.73 |
) |
|
|
$ |
4,136 |
|
|
$ |
0.12 |
|
|
|
$ |
(27,623 |
) |
|
$ |
(0.84 |
) |
|
|
$ |
9,083 |
|
|
$ |
0.26 |
|
|
Reconciling items from below |
|
|
30,250 |
|
|
|
0.92 |
|
|
|
|
665 |
|
|
|
0.02 |
|
|
|
|
31,584 |
|
|
|
0.96 |
|
|
|
|
(5,555 |
) |
|
|
(0.16 |
) |
|
Adjusted net income and adjusted EPS |
|
$ |
6,276 |
|
|
$ |
0.19 |
|
|
|
$ |
4,801 |
|
|
$ |
0.14 |
|
|
|
$ |
3,961 |
|
|
$ |
0.12 |
|
|
|
$ |
3,528 |
|
|
$ |
0.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of
Adjusted EBITDA |
|
Three Months Ended April 30,
2019 |
|
|
Three Months Ended April 30,
2018 |
|
|
Six Months Ended April 30,
2019 |
|
|
Six Months Ended April 30,
2018 |
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
|
Reconciliation |
|
|
|
Net (loss) income as reported |
|
$ |
(23,974 |
) |
|
|
|
|
$ |
4,136 |
|
|
|
|
|
$ |
(27,623 |
) |
|
|
|
|
$ |
9,083 |
|
|
|
|
Income tax expense (benefit) |
|
|
1,955 |
|
|
|
|
|
|
1,393 |
|
|
|
|
|
|
968 |
|
|
|
|
|
|
(6,167 |
) |
|
|
|
Other, net |
|
|
54 |
|
|
|
|
|
|
(264 |
) |
|
|
|
|
|
(202 |
) |
|
|
|
|
|
(689 |
) |
|
|
|
Interest expense |
|
|
2,602 |
|
|
|
|
|
|
2,502 |
|
|
|
|
|
|
5,044 |
|
|
|
|
|
|
4,943 |
|
|
|
|
Depreciation and amortization |
|
|
12,404 |
|
|
|
|
|
|
13,310 |
|
|
|
|
|
|
24,976 |
|
|
|
|
|
|
26,583 |
|
|
|
|
EBITDA |
|
|
(6,959 |
) |
|
|
|
|
|
21,077 |
|
|
|
|
|
|
3,163 |
|
|
|
|
|
|
33,753 |
|
|
|
|
Reconciling items from below |
|
|
30,311 |
|
|
|
|
|
|
244 |
|
|
|
|
|
|
32,282 |
|
|
|
|
|
|
622 |
|
|
|
|
Adjusted EBITDA |
|
$ |
23,352 |
|
|
|
|
|
$ |
21,321 |
|
|
|
|
|
$ |
35,445 |
|
|
|
|
|
$ |
34,375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciling
Items |
|
Three Months Ended April 30,
2019 |
|
|
Three Months Ended April 30,
2018 |
|
|
Six Months Ended April 30,
2019 |
|
|
Six Months Ended April 30,
2018 |
|
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
|
Income Statement |
|
Reconciling Items |
|
Net sales |
|
$ |
218,203 |
|
|
$ |
- |
|
|
|
$ |
214,212 |
|
|
$ |
- |
|
|
|
$ |
415,011 |
|
|
$ |
- |
|
|
|
$ |
405,878 |
|
|
$ |
- |
|
|
Cost of sales |
|
|
171,378 |
|
|
|
- |
|
|
|
|
169,030 |
|
|
|
- |
|
|
|
|
329,935 |
|
|
|
- |
|
|
|
|
323,546 |
|
|
|
- |
|
|
Selling, general and administrative |
|
|
23,722 |
|
|
|
(249 |
) |
(1) |
|
|
23,863 |
|
|
|
(2 |
) |
(1) |
|
|
51,748 |
|
|
|
(2,117 |
) |
(1) |
|
|
47,971 |
|
|
|
(14 |
) |
(1) |
Restructuring charges |
|
|
84 |
|
|
|
(84 |
) |
(2) |
|
|
242 |
|
|
|
(242 |
) |
(2) |
|
|
187 |
|
|
|
(187 |
) |
(2) |
|
|
608 |
|
|
|
(608 |
) |
(2) |
Asset impairment charges |
|
|
29,978 |
|
|
|
(29,978 |
) |
(3) |
|
|
- |
|
|
|
- |
|
|
|
|
29,978 |
|
|
|
(29,978 |
) |
(3) |
|
|
- |
|
|
|
- |
|
|
EBITDA |
|
|
(6,959 |
) |
|
|
30,311 |
|
|
|
|
21,077 |
|
|
|
244 |
|
|
|
|
3,163 |
|
|
|
32,282 |
|
|
|
|
33,753 |
|
|
|
622 |
|
|
Depreciation and amortization |
|
|
12,404 |
|
|
|
- |
|
|
|
|
13,310 |
|
|
|
(504 |
) |
(4) |
|
|
24,976 |
|
|
|
- |
|
|
|
|
26,583 |
|
|
|
(852 |
) |
(4) |
Operating loss |
|
|
(19,363 |
) |
|
|
30,311 |
|
|
|
|
7,767 |
|
|
|
748 |
|
|
|
|
(21,813 |
) |
|
|
32,282 |
|
|
|
|
7,170 |
|
|
|
1,474 |
|
|
Interest expense |
|
|
(2,602 |
) |
|
|
- |
|
|
|
|
(2,502 |
) |
|
|
- |
|
|
|
|
(5,044 |
) |
|
|
- |
|
|
|
|
(4,943 |
) |
|
|
- |
|
|
Other, net |
|
|
(54 |
) |
|
|
24 |
|
(5) |
|
|
264 |
|
|
|
132 |
|
(5) |
|
|
202 |
|
|
|
45 |
|
(5) |
|
|
689 |
|
|
|
(167 |
) |
(5) |
(Loss) income before income taxes |
|
|
(22,019 |
) |
|
|
30,335 |
|
|
|
|
5,529 |
|
|
|
880 |
|
|
|
|
(26,655 |
) |
|
|
32,327 |
|
|
|
|
2,916 |
|
|
|
1,307 |
|
|
Income tax (expense) benefit |
|
|
(1,955 |
) |
|
|
(85 |
) |
(6) |
|
|
(1,393 |
) |
|
|
(215 |
) |
(6) |
|
|
(968 |
) |
|
|
(743 |
) |
(6) |
|
|
6,167 |
|
|
|
(6,862 |
) |
(6) |
Net (loss) income |
|
$ |
(23,974 |
) |
|
$ |
30,250 |
|
|
|
$ |
4,136 |
|
|
$ |
665 |
|
|
|
$ |
(27,623 |
) |
|
$ |
31,584 |
|
|
|
$ |
9,083 |
|
|
$ |
(5,555 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted (loss) earnings per share |
|
$ |
(0.73 |
) |
|
|
|
|
$ |
0.12 |
|
|
|
|
|
$ |
(0.84 |
) |
|
|
|
|
$ |
0.26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Transaction
and advisory fees, and in the six months ended April 30,2019, $1.2
million of severance related to a reorganization. |
(2) Restructuring
charges relate to the closure of several manufacturing plant
facilities. |
(3) Asset
impairment charges relate to a goodwill impairment in the North
American Cabinet Components segment. |
(4) Accelerated
depreciation for plant re-layout in the North American Cabinet
Components segment. |
(5) Foreign
currency transaction losses (gains). |
(6) Impact on a
with and without basis. Six months ended April 30, 2019 and
2018 include $0.2 million and $6.5 million, respectively,
adjustment related to the Tax Cuts and Jobs Act. |
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
SELECTED SEGMENT DATA |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
This table provides operating (loss) income, EBITDA, and Adjusted
EBITDA by reportable segment. Non-operating expense and
income tax expense are not allocated to the reportable
segments. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NA Fenestration (1) |
|
EU Fenestration (1) |
|
NA Cabinet Components |
|
Unallocated Corp & Other |
|
Total |
Three months ended
April 30, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
115,346 |
|
|
$ |
41,623 |
|
|
$ |
62,836 |
|
|
$ |
(1,602 |
) |
|
$ |
218,203 |
|
Cost of sales |
|
|
90,031 |
|
|
|
28,906 |
|
|
|
53,699 |
|
|
|
(1,258 |
) |
|
|
171,378 |
|
Selling, general and administrative |
|
|
12,213 |
|
|
|
5,696 |
|
|
|
4,505 |
|
|
|
1,308 |
|
|
|
23,722 |
|
Restructuring charges |
|
|
84 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
84 |
|
Depreciation and amortization |
|
|
6,758 |
|
|
|
2,219 |
|
|
|
3,305 |
|
|
|
122 |
|
|
|
12,404 |
|
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Operating income (loss) |
|
|
6,260 |
|
|
|
4,802 |
|
|
|
(28,651 |
) |
|
|
(1,774 |
) |
|
|
(19,363 |
) |
Depreciation and amortization |
|
|
6,758 |
|
|
|
2,219 |
|
|
|
3,305 |
|
|
|
122 |
|
|
|
12,404 |
|
EBITDA |
|
|
13,018 |
|
|
|
7,021 |
|
|
|
(25,346 |
) |
|
|
(1,652 |
) |
|
|
(6,959 |
) |
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
249 |
|
|
|
249 |
|
Restructuring charges |
|
|
84 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
84 |
|
Adjusted EBITDA |
|
$ |
13,102 |
|
|
$ |
7,021 |
|
|
$ |
4,632 |
|
|
$ |
(1,403 |
) |
|
$ |
23,352 |
|
Adjusted EBITDA Margin % |
|
|
11.4 |
% |
|
|
16.9 |
% |
|
|
7.4 |
% |
|
|
|
|
|
|
10.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
April 30, 2018 (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
114,157 |
|
|
$ |
38,824 |
|
|
$ |
62,668 |
|
|
$ |
(1,437 |
) |
|
$ |
214,212 |
|
Cost of sales |
|
|
88,385 |
|
|
|
27,589 |
|
|
|
54,135 |
|
|
|
(1,079 |
) |
|
|
169,030 |
|
Selling, general and administrative (3) |
|
|
13,343 |
|
|
|
6,178 |
|
|
|
4,454 |
|
|
|
(112 |
) |
|
|
23,863 |
|
Restructuring charges |
|
|
238 |
|
|
|
- |
|
|
|
4 |
|
|
|
- |
|
|
|
242 |
|
Depreciation and amortization |
|
|
6,808 |
|
|
|
2,527 |
|
|
|
3,839 |
|
|
|
136 |
|
|
|
13,310 |
|
Operating income (loss) |
|
|
5,383 |
|
|
|
2,530 |
|
|
|
236 |
|
|
|
(382 |
) |
|
|
7,767 |
|
Depreciation and amortization |
|
|
6,808 |
|
|
|
2,527 |
|
|
|
3,839 |
|
|
|
136 |
|
|
|
13,310 |
|
EBITDA |
|
|
12,191 |
|
|
|
5,057 |
|
|
|
4,075 |
|
|
|
(246 |
) |
|
|
21,077 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2 |
|
|
|
2 |
|
Restructuring charges |
|
|
238 |
|
|
|
- |
|
|
|
4 |
|
|
|
- |
|
|
|
242 |
|
Adjusted EBITDA |
|
$ |
12,429 |
|
|
$ |
5,057 |
|
|
$ |
4,079 |
|
|
$ |
(244 |
) |
|
$ |
21,321 |
|
Adjusted EBITDA Margin % |
|
|
10.9 |
% |
|
|
13.0 |
% |
|
|
6.5 |
% |
|
|
|
|
|
|
10.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended April
30, 2019 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
224,395 |
|
|
$ |
76,877 |
|
|
$ |
116,688 |
|
|
$ |
(2,949 |
) |
|
$ |
415,011 |
|
Cost of sales |
|
|
177,184 |
|
|
|
53,431 |
|
|
|
101,555 |
|
|
|
(2,235 |
) |
|
|
329,935 |
|
Selling, general and administrative |
|
|
25,290 |
|
|
|
11,406 |
|
|
|
9,430 |
|
|
|
5,622 |
|
|
|
51,748 |
|
Restructuring charges |
|
|
187 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
187 |
|
Depreciation and amortization |
|
|
13,630 |
|
|
|
4,456 |
|
|
|
6,644 |
|
|
|
246 |
|
|
|
24,976 |
|
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Operating income (loss) |
|
|
8,104 |
|
|
|
7,584 |
|
|
|
(30,919 |
) |
|
|
(6,582 |
) |
|
|
(21,813 |
) |
Depreciation and amortization |
|
|
13,630 |
|
|
|
4,456 |
|
|
|
6,644 |
|
|
|
246 |
|
|
|
24,976 |
|
EBITDA |
|
|
21,734 |
|
|
|
12,040 |
|
|
|
(24,275 |
) |
|
|
(6,336 |
) |
|
|
3,163 |
|
Asset impairment charges |
|
|
- |
|
|
|
- |
|
|
|
29,978 |
|
|
|
- |
|
|
|
29,978 |
|
Transaction and advisory fees |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
2,117 |
|
|
|
2,117 |
|
Restructuring charges |
|
|
187 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
187 |
|
Adjusted EBITDA |
|
$ |
21,921 |
|
|
$ |
12,040 |
|
|
$ |
5,703 |
|
|
$ |
(4,219 |
) |
|
$ |
35,445 |
|
Adjusted EBITDA Margin % |
|
|
9.8 |
% |
|
|
15.7 |
% |
|
|
4.9 |
% |
|
|
|
|
|
|
8.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six months ended April
30, 2018 (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
$ |
216,883 |
|
|
$ |
72,820 |
|
|
$ |
118,590 |
|
|
$ |
(2,415 |
) |
|
$ |
405,878 |
|
Cost of sales |
|
|
168,482 |
|
|
|
52,421 |
|
|
|
104,351 |
|
|
|
(1,708 |
) |
|
|
323,546 |
|
Selling, general and administrative (3) |
|
|
26,845 |
|
|
|
11,506 |
|
|
|
9,088 |
|
|
|
532 |
|
|
|
47,971 |
|
Restructuring charges |
|
|
489 |
|
|
|
- |
|
|
|
119 |
|
|
|
- |
|
|
|
608 |
|
Depreciation and amortization |
|
|
13,819 |
|
|
|
4,976 |
|
|
|
7,525 |
|
|
|
263 |
|
|
|
26,583 |
|
Operating income (loss) |
|
|
7,248 |
|
|
|
3,917 |
|
|
|
(2,493 |
) |
|
|
(1,502 |
) |
|
|
7,170 |
|
Depreciation and amortization |
|
|
13,819 |
|
|
|
4,976 |
|
|
|
7,525 |
|
|
|
263 |
|
|
|
26,583 |
|
EBITDA |
|
|
21,067 |
|
|
|
8,893 |
|
|
|
5,032 |
|
|
|
(1,239 |
) |
|
|
33,753 |
|
Transaction related costs |
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
14 |
|
|
|
14 |
|
Restructuring charges |
|
|
489 |
|
|
|
- |
|
|
|
119 |
|
|
|
- |
|
|
|
608 |
|
Adjusted EBITDA |
|
$ |
21,556 |
|
|
$ |
8,893 |
|
|
$ |
5,151 |
|
|
$ |
(1,225 |
) |
|
$ |
34,375 |
|
Adjusted EBITDA Margin % |
|
|
9.9 |
% |
|
|
12.2 |
% |
|
|
4.3 |
% |
|
|
|
|
|
|
8.5 |
% |
|
|
|
|
|
|
|
|
|
|
|
(1) NA
Fenestration and EU Fenestration were previously named "NA
Engineered Components" and "EU Engineered Components,"
respectively. |
|
|
|
|
(2) Updated to reflect the
adoption of ASU 2017-07. |
|
|
|
|
|
|
|
|
|
|
(3) Updated to
reflect a reduction in corporate allocations of $0.3 and $0.9
million during the three and six months ended April 30, 2018 due to
a change in allocation methodology during the fourth quarter of
2018. |
|
|
QUANEX BUILDING PRODUCTS CORPORATION |
SALES ANALYSIS |
(In thousands) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
April 30, 2019 |
|
April 30, 2018 |
|
April 30, 2019 |
|
April 30, 2018 |
|
|
|
|
|
|
|
|
|
NA
Fenestration: |
|
|
|
|
|
|
|
|
United States - fenestration |
$ |
99,144 |
|
|
$ |
97,005 |
|
|
$ |
193,029 |
|
|
$ |
184,787 |
|
|
International -
fenestration |
|
8,096 |
|
|
|
8,897 |
|
|
|
16,302 |
|
|
|
15,906 |
|
|
United States -
non-fenestration |
|
4,803 |
|
|
|
4,697 |
|
|
|
8,308 |
|
|
|
8,843 |
|
|
International -
non-fenestration |
|
3,303 |
|
|
|
3,558 |
|
|
|
6,756 |
|
|
|
7,347 |
|
|
|
$ |
115,346 |
|
|
$ |
114,157 |
|
|
$ |
224,395 |
|
|
$ |
216,883 |
|
EU
Fenestration (1): |
|
|
|
|
|
|
|
|
International -
fenestration |
$ |
34,973 |
|
|
$ |
32,847 |
|
|
$ |
65,696 |
|
|
$ |
62,716 |
|
|
International -
non-fenestration |
|
6,650 |
|
|
|
5,977 |
|
|
|
11,181 |
|
|
|
10,104 |
|
|
|
$ |
41,623 |
|
|
$ |
38,824 |
|
|
$ |
76,877 |
|
|
$ |
72,820 |
|
NA Cabinet
Components: |
|
|
|
|
|
|
|
|
United States -
fenestration |
$ |
2,997 |
|
|
$ |
3,403 |
|
|
$ |
6,349 |
|
|
$ |
6,850 |
|
|
United States -
non-fenestration |
|
59,220 |
|
|
|
58,698 |
|
|
|
109,181 |
|
|
|
110,703 |
|
|
International -
non-fenestration |
|
619 |
|
|
|
567 |
|
|
|
1,158 |
|
|
|
1,037 |
|
|
|
$ |
62,836 |
|
|
$ |
62,668 |
|
|
$ |
116,688 |
|
|
$ |
118,590 |
|
Unallocated Corporate & Other: |
|
|
|
|
|
|
|
|
Eliminations |
$ |
(1,602 |
) |
|
$ |
(1,437 |
) |
|
$ |
(2,949 |
) |
|
$ |
(2,415 |
) |
|
|
$ |
(1,602 |
) |
|
$ |
(1,437 |
) |
|
$ |
(2,949 |
) |
|
$ |
(2,415 |
) |
|
|
|
|
|
|
|
|
|
Net
Sales |
$ |
218,203 |
|
|
$ |
214,212 |
|
|
$ |
415,011 |
|
|
$ |
405,878 |
|
|
|
|
|
|
|
|
|
|
(1) Reflects
reductions of $2.8 million and $4.4 million in revenue associated
with foreign currency exchange rate impacts for the three and six
months ended April 30, 2019. |
|
|
|
|
|
|
|
|
|
Quanex (NYSE:NX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Quanex (NYSE:NX)
Historical Stock Chart
From Apr 2023 to Apr 2024